We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01152801
First Posted: June 29, 2010
Last Update Posted: June 24, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )